Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-30T08:38:00.068Z Has data issue: false hasContentIssue false

The effects of N-acetylcysteine on ovulation and sex hormones profile in women with polycystic ovary syndrome: a systematic review and meta-analysis

Published online by Cambridge University Press:  04 January 2023

Zahra Shahveghar Asl
Affiliation:
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Karim Parastouei*
Affiliation:
Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Eslam Eskandari
Affiliation:
Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
*
*Corresponding author: Dr K. Parastouei, email parastouei@gmail.com

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases characterised by unusual levels of sex hormones and dysfunction of the ovaries. The infertility rate is high among patients with PCOS. Unusual hormonal status can lead to the inability of ovaries to release functional and mature follicles. Clinical trials on the effects of N-acetylcysteine (NAC) supplementation on ovulation and sex hormones profile in women with PCOS have been controversial. We performed a systematic review and meta-analysis to evaluate the potential effects of NAC supplementation on ovulation and sex hormones profile. PubMed, Scopus, Embase, Web of Science and Cochrane Central library international databases were searched till September 2021. Meta-analysis was performed using a random-effects approach in case of significant between-study heterogeneity. Eighteen studies, including 2185 participants, were included in the present meta-analysis. NAC significantly reduced total testosterone (TT) levels (standardised mean difference (SMD): −0·25 ng/ml; 95 % CI (−0·39, −0·10); ‘P < 0·001’, I 2 = 53·9 %, P = 0·034) and increased follicle-stimulating hormone (FSH) levels (SMD: 0·39 mg/ml; 95 % CI (0·07, 0·71); P = 0·01, I 2 = 70·9 %, P = 0·002). Oestrogen levels also increased after correcting publication bias. However, no significant effect was observed on the number of follicles, endometrial thickness, progesterone, serum luteinising hormone levels and sex hormone-binding globulin. The results indicated that NAC supplementation decreased TT levels and increased FSH levels. Overall, NAC supplementation might be effective in the improvement of reproductive system function in patients with PCOS.

Type
Systematic Review and Meta-Analysis
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

De Leo, V, Musacchio, M, Cappelli, V, et al. (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14, 117.CrossRefGoogle ScholarPubMed
Alchami, A, O’Donovan, O & Davies, M (2015) PCOS: diagnosis and management of related infertility. Obstet Gynaecol Reprod Med 25, 279282.CrossRefGoogle Scholar
Melo, AS, Ferriani, RA & Navarro, PA (2015) Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics 70, 765769.CrossRefGoogle ScholarPubMed
Jonard, S & Dewailly, D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10, 107117.CrossRefGoogle ScholarPubMed
Ghomian, N, Khadem, N, Moeindarbari, S, et al. (2019) Comparison of pregnancy rate in patients with polycystic ovary syndrome treated with clomiphene alone and in combination with N-acetyl cysteine: a randomized clinical trial. Int J Women’s Health Reprod Sci 7, 185189.CrossRefGoogle Scholar
Faghfouri, AH, Zarezadeh, M, Tavakoli-Rouzbehani, OM, et al. (2020) The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: a systematic review and meta-analysis of controlled clinical trials. Eur J Pharmacol 884, 173368.CrossRefGoogle ScholarPubMed
Teimouri, B, Mollashahi, S, Paracheh, M, et al. (2021) Comparison of the effect of letrozole alone with letrozole plus n-acetylcysteine on pregnancy rate in patients with polycystic ovarian syndrome: a randomized clinical trial. Int J Women’s Health Reprod Sci 9, 7579.CrossRefGoogle Scholar
Maged, AM, Elsawah, H, Abdelhafez, A, et al. (2015) The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with polycystic ovary syndrome. Gynecol Endocrinol 31, 635638.CrossRefGoogle ScholarPubMed
Nasr, A (2010) Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reprod Biomed Online 20, 403409.CrossRefGoogle ScholarPubMed
Jannatifar, R, Parivar, K, Roodbari, NH, et al. (2019) Effects of N-acetyl-cysteine supplementation on sperm quality, chromatin integrity and level of oxidative stress in infertile men. Reprod Biol Endocrinol 17, 19.CrossRefGoogle ScholarPubMed
Oner, G & Muderris, II (2011) Clinical, endocrine and metabolic effects of metformin v. N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 159, 127131.CrossRefGoogle Scholar
Nemati, M, Nemati, S, Taheri, A-M, et al. (2017) Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome. J Gynecol Obstet Hum Reprod 46, 579585.CrossRefGoogle ScholarPubMed
Badawy, A, State, O & Abdelgawad, S (2007) N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet Gynecol Scand 86, 218222.CrossRefGoogle ScholarPubMed
Luo, J, Ao, Z, Duan, Z, et al. (2021) Effects of N-Acetylcysteine on the reproductive performance, oxidative stress and RNA sequencing of Nubian goats. Vet Med Sci 7, 156163.CrossRefGoogle ScholarPubMed
Shahrzad, E, Shariati, M, Naimi, S, et al. (2020) Protective effect of N-acetylcysteine on changes in serum levels of Pituitary–Gonadal axis hormones and testicular tissue in acrylamide-treated adult rats. Adv Hum Biol 10, 16.Google Scholar
Moghadam, MH, Shariati, M, Naeimi, S, et al. (2020) Influence of N-acetylcysteine on pituitary-gonadal axis hormones and protamine expression level in streptozotocin-induced diabetic male rats. Asian Pac J Reprod 9, 89.Google Scholar
Carmina, E & Azziz, R (2006) Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 86, S7S8.CrossRefGoogle ScholarPubMed
Hassan, M, Alalfy, M, Hassan, H, et al. (2019) Combined N-Acetylcysteine and clomiphene citrate for ovulation induction in polycystic ovary syndrome, a double blind randomized controlled trial. Austin J Obstet Gynecol 6, 1134.Google Scholar
Higgins, JP, Altman, DG, Gøtzsche, PC, et al. (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928.CrossRefGoogle ScholarPubMed
Badawy, A, El Nashar, A & El Totongy, M (2006) Clomiphene citrate plus N-acetyl cysteine v. clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril 86, 647650.CrossRefGoogle Scholar
Elnashar, A, Fahmy, M, Mansour, A, et al. (2007) N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertil Steril 88, 406409.CrossRefGoogle ScholarPubMed
Hashim, AH, Anwar, K & El-Fatah, RA (2010) N-acetyl cysteine plus clomiphene citrate v. metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. J Women’s Health 19, 20432048.CrossRefGoogle Scholar
Elgindy, EA, El-Huseiny, AM, Mostafa, MI, et al. (2010) N-Acetyl cysteine: could it be an effective adjuvant therapy in ICSI cycles? A preliminary study. Reprod Biomed Online 20, 789796.CrossRefGoogle ScholarPubMed
El Sharkwy, IA & Abd El Aziz, WM (2019) Randomized controlled trial of N-acetylcysteine v. l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. Int J Gynecol Obstet 147, 5964.CrossRefGoogle Scholar
Cheraghi, E, Mehranjani, MS, Shariatzadeh, MA, et al. (2016) N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev 28, 723731.CrossRefGoogle ScholarPubMed
Kose, SA & Naziroglu, M (2015) N-acetyl cysteine reduces oxidative toxicity, apoptosis, and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome. Free Radic Res 49, 338346.CrossRefGoogle ScholarPubMed
Chandil, N, Pande, S, Sen, SS, et al. (2019) Comparison of metformin and N acetylcysteine on clinical, metabolic parameter and hormonal profile in women with polycystic ovarian syndrome. J Obstet Gynecol India 69, 7781.CrossRefGoogle Scholar
Gayatri, K, Kumar, JS & Kumar, BB (2010) Metformin and N-acetyl cysteine in polycystic ovarian syndrome – a comparative study. Indian J Clin Med 1, 713. CrossRefGoogle Scholar
Fulghesu, AM, Ciampelli, M, Muzj, G, et al. (2002) N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 77, 11281135.CrossRefGoogle ScholarPubMed
Helal, MA (2016) The effects of N-acetyl-L-cysteine on the female reproductive performance and nephrotoxicity in rats. Ren Fail 38, 311320.CrossRefGoogle ScholarPubMed
Naimi, M, Shariati, M, Naimi, S, et al. (2019) N-Acetylcysteine improves acrylamide-induced changes in ovarian tissue and serum levels of pituitary-ovarian axis hormones in adult rats. Eur J Biol 78, 7581.Google Scholar
Cavallini, G, Ferraretti, AP, Gianaroli, L, et al. (2004) Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl 25, 761770.CrossRefGoogle ScholarPubMed
Diamanti-Kandarakis, E, Kandarakis, H & Legro, RS (2006) The role of genes and environment in the etiology of PCOS. Endocrine 30, 1926.CrossRefGoogle ScholarPubMed
Sriprasert, I, Kono, N, Karim, R, et al. (2020) Factors associated with serum estradiol levels among postmenopausal women using hormone therapy. Obstet Gynecol 136, 675684.CrossRefGoogle ScholarPubMed
Gruber, CJ, Tschugguel, W, Schneeberger, C, et al. (2002) Production and actions of estrogens. N Engl J Med 346, 340352.CrossRefGoogle ScholarPubMed
Rinaldi, S, Peeters, P, Bezemer, I, et al. (2006) Relationship of alcohol intake and sex steroid concentrations in blood in pre-and post-menopausal women: the European prospective investigation into cancer and nutrition. Cancer Causes Control 17, 10331043.CrossRefGoogle ScholarPubMed
Shafrir, AL, Zhang, X, Poole, EM, et al. (2014) The association of reproductive and lifestyle factors with a score of multiple endogenous hormones. Horm Cancer 5, 324335.CrossRefGoogle ScholarPubMed
Sarkola, T, Mäkisalo, H, Fukunaga, T, et al. (1999) Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women. Alcohol Clin Exp Res 23, 976982.CrossRefGoogle ScholarPubMed
Ginsburg, ES, Mello, NK, Mendelson, JH, et al. (1996) Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA 276, 17471751.CrossRefGoogle ScholarPubMed
Michnovicz, JJ, Hershcopf, RJ, Naganuma, H, et al. (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315, 13051309.CrossRefGoogle ScholarPubMed
Ruan, X & Mueck, A (2015) Impact of smoking on estrogenic efficacy. Climacteric 18, 3846.CrossRefGoogle ScholarPubMed
Rice, S, Elia, A, Jawad, Z, et al. (2013) Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 98, E14911500.CrossRefGoogle ScholarPubMed
Rezaei, N, Mardanshahi, T, Shafaroudi, MM, et al. (2018) Effects of l-Carnitine on the follicle-stimulating hormone, luteinizing hormone, testosterone, and testicular tissue oxidative stress levels in streptozotocin-induced diabetic rats. J Evid Based Integr Med 23, 110.CrossRefGoogle ScholarPubMed
Fathizadeh, H, Milajerdi, A, Reiner, Ž, et al. (2020) The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord 19, 18791894.CrossRefGoogle Scholar
Nakamura, K, Nashimoto, M, Matsuyama, S, et al. (2001) Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition 17, 921925.CrossRefGoogle ScholarPubMed
Steiner, AZ, Herring, AH, Kesner, JS, et al. (2011) Antimüllerian hormone as a predictor of natural fecundability in women aged 30–42 years. Obstet Gynecol 117, 798804.CrossRefGoogle ScholarPubMed
Sadowska, AM, Manuel, YKB & De Backer, WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 20, 922.CrossRefGoogle ScholarPubMed
Paschalis, V, Theodorou, AA, Margaritelis, NV, et al. (2018) N-acetylcysteine supplementation increases exercise performance and reduces oxidative stress only in individuals with low levels of glutathione. Free Radic Biol Med 115, 288297.CrossRefGoogle ScholarPubMed
Xiong, T, Zhang, Z, Zheng, R, et al. (2019) N-acetyl cysteine inhibits lipopolysaccharide-induced apoptosis of human umbilical vein endothelial cells via the p38MAPK signaling pathway. Mol Med Rep 20, 29452953.Google ScholarPubMed
Atkuri, KR, Mantovani, JJ, Herzenberg, LA, et al. (2007) N-Acetylcysteine – a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7, 355359.CrossRefGoogle ScholarPubMed
Supplementary material: File

Shahveghar Asl et al. supplementary material

Figures S1-S8

Download Shahveghar Asl et al. supplementary material(File)
File 1.3 MB